Tiziana Life Sciences Ltd (TLSA) reporting calendar
Tiziana Life Sciences Ltd files periodic reports with the SEC as TLSA on Nasdaq. Atlas tracks 8 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 1 May 2026
- Reports on record
- 8
Open TLSA market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 1 May 2026 | 121 days | 0001213900-26-051015 |
| 20-F | 31 Dec 2024 | 6 May 2025 | 126 days | 0001213900-25-040218 |
| 20-F | 31 Dec 2023 | 10 May 2024 | 131 days | 0001213900-24-041808 |
| 20-F | 31 Dec 2022 | 26 Apr 2023 | 116 days | 0001213900-23-032763 |
| 20-F | 31 Dec 2021 | 23 May 2022 | 143 days | 0001213900-22-028645 |
| 20-F | 31 Dec 2020 | 17 May 2021 | 137 days | 0001213900-21-027177 |
| 20-F | 31 Dec 2019 | 17 Jun 2020 | 169 days | 0001213900-20-015211 |
| 20-F | 31 Dec 2018 | 4 Apr 2019 | 94 days | 0001213900-19-005736 |
Source: SEC EDGAR company submissions for CIK 0001723069. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.